2258608-78-3
Chemical Structure
UCM-1306
- CAS 番号: 2258608-78-3
- Formula:C14H14FNO2S
- Molecular Weight:279.33
IUPAC Name: (2'-(fluoromethoxy)-[1,1'-biphenyl]-4-yl)(imino)(methyl)-l6-sulfanone
InChIKey: VCSBOASGFYJGGT-UHFFFAOYSA-N
SMILES: O=S(C1=CC=C(C2=C(OCF)C=CC=C2)C=C1)(C)=N
Biological Activity: UCM-1306 is a potent and orally active human dopamine D1 receptor allosteric modulator (PAM). UCM-1306 increases the endogenous dopamine (DA) maximal effect both in human and mouse D1 receptors. UCM-1306 is not only for improving motor symptoms but also for addressing the key comorbid cognitive impairment associated with long-term Parkinson’s disease (PD)[1].
| 製品番号 | 製品名 | 純度 | 製品説明 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
UCM-1306 | 99.49% | UCM-1306 is a potent and orally active human dopamine D1 receptor allosteric modulator (PAM). UCM-1306 increases the endogenous dopamine (DA) maximal effect both in human and mouse D1 receptors. UCM-1306 is not only for improving motor symptoms but also for addressing the key comorbid cognitive impairment associated with long-term Parkinson’s disease (PD). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
